Back to results
Active, not recruitingPhase 2

Rapamycin - Effects on Alzheimer's and Cognitive Health

NCT04629495

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases

San Antonio, Texas, United States

View on ClinicalTrials.gov
Rapamycin - Effects on Alzheimer's and Cognitive Health — TrialFind